United Parcel Service (UPS) completed the acquisition of Andlauer Healthcare Group for $1.6 billion, enhancing its healthcare logistics capabilities. UPS reported better-than-expected Q3 earnings, with EPS of $1.74 and revenues of $21.4 billion. Despite outperformance, low shipment volumes continue to be a challenge, impacting international margins and overall share performance.

UPS provided upbeat Q4 guidance, with projected revenues of $24 billion and an adjusted operating margin of 11-11.5%. The company expects capital expenditures of $3.5 billion, dividend payments of $5.5 billion, and share repurchases of $1 billion. UPS’ earnings beat in Q3 maintained its impressive track record.

The expiration of the De Minimis exemption could hurt international markets by diverting volumes from the China-US trade lane. UPS stock has declined over 25% YTD due to tariff issues and declining volumes. Despite being undervalued, near-term risks outweigh positives. Investors are advised to hold onto UPS stock and wait for a better entry point.

Zacks Investment Research has identified UPS as a stock to watch, with the potential to at least double in value. The company’s shareholder-friendly approach and recent acquisition of Andlauer Healthcare are positive factors. However, uncertainty related to tariffs and volume challenges remain key risks. Holding onto UPS stock is advised for now.

Read more at Nasdaq: Should Investors Bet on UPS Post Its Andlauer Healthcare Buyout?